Skip to content

Clinical trials

Completed Phase 3 Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemia Phase: Phase 3 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20035
20043
20052
20062
20074
20081
20092
20151
20181
20193

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acusphere2
AstraZeneca2
Beijing Northland Biotech. Co., Ltd.2
Merck Sharp & Dohme LLC2
Pfizer2
Sangart2
Abbott Medical Devices1
Astellas Pharma Inc1
CoAxia1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemia25
Coronary Artery Disease9
Myocardial Ischemia7
Stroke7
Angina Pectoris4
Heart Diseases4
Myocardial Infarction4
Arterial Occlusive Diseases3
Cardiovascular Diseases3
Vascular Diseases3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.